Literature DB >> 28567365

Mesenchymal stromal cells and ischemic heart disease: hitting the target?

Donald G Phinney1.   

Abstract

Entities:  

Year:  2017        PMID： 28567365      PMCID： PMC5440261          DOI： 10.21037/cdt.2016.12.04

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN： 2223-3652


× No keyword cloud information.
  20 in total

1.  Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial.

Authors:  Kai C Wollert; Gerd P Meyer; Joachim Lotz; Stefanie Ringes-Lichtenberg; Peter Lippolt; Christiane Breidenbach; Stephanie Fichtner; Thomas Korte; Burkhard Hornig; Diethelm Messinger; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Lancet       Date:  2004 Jul 10-16       Impact factor: 79.321

2.  A critical challenge: dosage-related efficacy and acute complication intracoronary injection of autologous bone marrow mesenchymal stem cells in acute myocardial infarction.

Authors:  Lian R Gao; Xue T Pei; Qing A Ding; Yu Chen; Ning K Zhang; Hai Y Chen; Zhi G Wang; Yun F Wang; Zhi M Zhu; Tian C Li; Hui L Liu; Zi C Tong; Yong Yang; Xue Nan; Feng Guo; Jian L Shen; Yan H Shen; Jian J Zhang; Yu X Fei; Hong T Xu; Li H Wang; Hai T Tian; Da Q Liu; Ye Yang
Journal:  Int J Cardiol       Date:  2013-05-04       Impact factor: 4.164

3.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

4.  Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling.

Authors:  Adam R Williams; Barry Trachtenberg; Darcy L Velazquez; Ian McNiece; Peter Altman; Didier Rouy; Adam M Mendizabal; Pradip M Pattany; Gustavo A Lopera; Joel Fishman; Juan P Zambrano; Alan W Heldman; Joshua M Hare
Journal:  Circ Res       Date:  2011-03-17       Impact factor: 17.367

5.  A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction.

Authors:  Joshua M Hare; Jay H Traverse; Timothy D Henry; Nabil Dib; Robert K Strumpf; Steven P Schulman; Gary Gerstenblith; Anthony N DeMaria; Ali E Denktas; Roger S Gammon; James B Hermiller; Mark A Reisman; Gary L Schaer; Warren Sherman
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

6.  Development of a flow cytometry-based potency assay for measuring the in vitro immunomodulatory properties of mesenchymal stromal cells.

Authors:  Andreia Ribeiro; Thomas Ritter; Matthew Griffin; Rhodri Ceredig
Journal:  Immunol Lett       Date:  2016-07-20       Impact factor: 3.685

7.  Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).

Authors:  Anders Bruun Mathiasen; Abbas Ali Qayyum; Erik Jørgensen; Steffen Helqvist; Anne Fischer-Nielsen; Klaus F Kofoed; Mandana Haack-Sørensen; Annette Ekblond; Jens Kastrup
Journal:  Eur Heart J       Date:  2015-04-29       Impact factor: 29.983

8.  Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial.

Authors:  Lian R Gao; Yu Chen; Ning K Zhang; Xi L Yang; Hui L Liu; Zhi G Wang; Xiao Y Yan; Yu Wang; Zhi M Zhu; Tian C Li; Li H Wang; Hai Y Chen; Yun D Chen; Chao L Huang; Peng Qu; Chen Yao; Bin Wang; Guang H Chen; Zhong M Wang; Zhao Y Xu; Jing Bai; Di Lu; Yan H Shen; Feng Guo; Mu Y Liu; Yong Yang; Yan C Ding; Ye Yang; Hai T Tian; Qing A Ding; Li N Li; Xin C Yang; Xiang Hu
Journal:  BMC Med       Date:  2015-07-10       Impact factor: 8.775

9.  Potency Biomarker Signature Genes from Multiparametric Osteogenesis Assays: Will cGMP Human Bone Marrow Mesenchymal Stromal Cells Make Bone?

Authors:  Alba Murgia; Elena Veronesi; Olivia Candini; Anna Caselli; Naomi D'souza; Valeria Rasini; Andrea Giorgini; Fabio Catani; Lorenzo Iughetti; Massimo Dominici; Jorge S Burns
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

10.  A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction.

Authors:  Jun-Won Lee; Seung-Hwan Lee; Young-Jin Youn; Min-Soo Ahn; Jang-Young Kim; Byung-Su Yoo; Junghan Yoon; Woocheol Kwon; In-Soo Hong; Kyounghoon Lee; Jun Kwan; Keum Soo Park; Donghoon Choi; Yang Soo Jang; Mun K Hong
Journal:  J Korean Med Sci       Date:  2013-12-26       Impact factor: 2.153
View more
  1 in total

1.  Extracellular vesicles derived from mesenchymal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome.

Authors:  Alison Accarie; Bruno l'Homme; Mohamed Amine Benadjaoud; Sai Kiang Lim; Chandan Guha; Marc Benderitter; Radia Tamarat; Alexandra Sémont
Journal:  Stem Cell Res Ther       Date:  2020-08-27       Impact factor: 8.079
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.